CD25/IL-2R alpha Antibody (Daclizumab) - Chimeric - Azide and BSA Free, Novus Biologicals™

CD25/IL-2 R alpha

Flow Cytometry 1:10 - 1:1000, Blocking/Neutralizing 50 - 200 molar excess, CyTOF-ready

Monoclonal

Purified

RUO

Human

CD25, CD25 antigen, IDDM10, IL-2 receptor subunit alpha, IL2R, IL-2R subunit alpha, IL-2-RA, IL2-RA, interleukin 2 receptor, alpha, interleukin-2 receptor subunit alpha, p55, TAC antigen, TCGFR

IL2RA

IgG

Protein A or G purified

Binds to p55 chain of IL2R on human T cells, Tac antigen, which is expressed on T cells activated by mitogens, soluble antigens, and alloantigens but not on resting T cells, thymocytes, B cells, monocytes, activated B cells, leukemic T cell blasts from patients with acute lymphoblastic leukemia, and long-term T cell lines.

Daclizumab

Flow Cytometry, Blocking Assay, CyTOF

Unconjugated

Rabbit

Adaptive Immunity, Apoptosis, B Cell Development and Differentiation Markers, Biologically Active Proteins, Cytokine Research, Diabetes Research, Immunology, Innate Immunity, Mast Cell Markers, Signal Transduction

PBS with 0.02% Proclin 300. with 0.02% Proclin 300

3559

Cultured T-cells derived from a patient with Mycosis fungoides.

Primary

Store at 4C for up to 3 months. For longer storage, aliquot and store at -20C.